ANTIBODY TO HUMAN ACQUIRED IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) - ANVISA Registration 10071770701

Access comprehensive regulatory information for ANTIBODY TO HUMAN ACQUIRED IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10071770701 and manufactured by ABBOTT DIAGNOSTICS KOREA INC.. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Jun 15, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU BIOTEST BIOTECH CO., LTD, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10071770701
2 Related Devices
Registration Details
ANVISA Registration Number: 10071770701
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10071770701

25351134550201390

50248780000161

Company Information

South Korea
PT: CORÉIA DO SUL

Dates and Status

May 20, 2013

15/06/2034

09/18/2025 19:00:01

Registration Details

10071770701

25351134550201390

50248780000161

Company Information

Dates and Status

May 20, 2013

15/06/2034

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "ANTIBODY TO HUMAN ACQUIRED IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV)"